Overview
TRIB market data
Price History
TRIB price chart · 1M
- O
- 12.07
- H
- 12.07
- L
- 12.07
- C
- 12.07
- Vol
- 0.000000
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $12.07
- Previous Close
- $12.07
- Day High
- $12.07
- Day Low
- $12.07
- 52 Week High
- $21.53
- 52 Week Low
- $0.30
- 7 Day Return
- +0.00%
- 30 Day Return
- +39.06%
- 90 Day Return
- -43.33%
- 1 Year Return
- -34.62%
- Daily Notional Volume
- $0 Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.10 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.99 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -72.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.94 – $52.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.7M · P/B 5.27 · P/S 0.13.
Company News
Trinity Biotech's Trinovium Announces Strategic Collaboration With Echelon Data Centres To Develop Liquid Cooling Solutions For AI Data CentersBenzinga · Aug 17, 2026, 12:34 PM
Trinity Biotech Receives ~$7M Of Additional Investment From Funds Managed By Perceptive Advisors; Regains Compliance With Nasdaq Minimum Bid Price RequirementBenzinga · Aug 14, 2026, 1:35 PM
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · Jul 24, 2026, 12:55 PM
Trinity Biotech shares are trading lower after the company announced a ADS ratio change that has the same effect of a 1-for-30 reverse ADS split.Benzinga · Jul 22, 2026, 1:04 PM
Trinity Biotech Enters Collaboration With Intradermal Drug Delivery Platform Maker Latch MedicalBenzinga · Jul 22, 2026, 11:35 AM
Trinity Biotech Announces ADS Ratio Change From One ADS Representing 20 Ordinary Shares To One ADS Representing 600 Ordinary SharesBenzinga · Jul 22, 2026, 11:19 AM
Trinity Biotech Announces Clinical Study Results Showing Next-Gen CGM+ Wearable Biosensor Platform Delivers Purpose-Built Capability To Identify Nocturnal Compression-Related False Low Glucose EventsBenzinga · Jul 2, 2026, 12:40 PM
Trinity Biotech’s Unit Trinovium Secures Silver Membership In Open Compute Project To Directly Engage With Global Ecosystem Shaping Next-Gen Data Center InfrastructureBenzinga · Jun 30, 2026, 1:05 PM
Trinity Biotech Terminates Standby Equity Purchase Agreement With YA IIBenzinga · Jun 29, 2026, 7:20 PM
Trinity Biotech Launches Trinovium, Subsidiary Focused On Advanced Liquid Cooling Solutions And Fluid Intelligence Systems For Next-Gen AI Data CentersBenzinga · Jun 23, 2026, 11:45 AM